CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Qiagen NV is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Qiagen NV
Hulsterweg 82
Phone: +31 773556600p:+31 773556600 VENLO, 5912 PL  Netherlands Ticker: QIAQIA
Business Summary
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes---Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8071 Medical laboratories
3826 Laboratory analytical instruments
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board Lawrence A.Rosen 66 8/21/2020 1/1/2013
Chief Executive Officer, Managing Director, Member of the Executive Board ThierryBernard 58 6/30/2020
Managing Director, Chief Financial Officer, Member of the Executive Board RolandSackers 54 1/1/2016 1/1/2004
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
QIAGEN Ltd. SKELTON HOUSE LLOYD STREET NORTH UK
Blirt SA Trzy Lipy 3/1.38 Gdansk Poland
QIAGEN GmbH QIAGEN Strasse 1 Hilden Germany
11 additional Subsidiary records available in full report.

Business Names
Business Name
AmniSure International LLC
Blirt SA
Cellestis Limited
40 additional Business Names available in full report.

General Information
Number of Employees: 6,100 (As of 6/30/2023)
Outstanding Shares: 228,182,000 (As of 6/30/2023)
Shareholders: 70
Stock Exchange: ETR
Fax Number: +31 773208409


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 27, 2023